In the original publication, the data have been incorrectly updated within the results, discussion and Table 2 . The correct data are given here.
The result in Table 2 , presenting Hypoglycemic events at Week 12 currently reads: 2 (1.7).
This result should read: 2 (3.2). The result in Table 2 presenting Hypoglycemic events at Week 36 reads: 3 (2.5).
This result should read: 3 (4.8).
The result in Table 2 presenting the Hypoglycemic events p value currently reads: 1.000.
This p value should read: 0.500.
The statement within the results section reads:
'There was no significant difference in the incidence of hypoglycemia before and after treatment (1.7% vs. 2.5% v 2 = 0.21; p = 1.000) ( Table 2) .' This statement should read: 'There was no significant difference in the incidence of hypoglycemia before and after treatment (3.2% vs. 4.8% v 2 = 0.50; p = 0.500) ( Table 2) . ' The statement the discussion section reads: 'In particular, the 40% of subjects in the present study who. ' This statement should read: 'In particular, the 36.7% of subjects in the present study who.'
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